PHARMACEUTICAL PREPARATIONS TREAT OR

Brand Owner (click to sort) Address Description
BELVIQ ER Arena Pharmaceuticals GmbH Untere Bruhlstrasse 4 CH-4800 Zofingen Switzerland Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; pharmaceutical preparations to treat and prevent diabetes; pharmaceutical preparations to promote the cessation of smoking;ER;
BELVIQ SR Arena Pharmaceuticals GmbH Untere Bruhlstrasse 4 CH-4800 Zofingen Switzerland Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; pharmaceutical preparations to treat and prevent diabetes; pharmaceutical preparations to promote the cessation of smoking;SR;
BELVIQ XR EISAI INC. 200 Metro Blvd. Nutley NJ 07110 Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; pharmaceutical preparations to treat and prevent diabetes; pharmaceutical preparations to promote the cessation of smoking;XR;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.